Search results
Screening recommendations should be adapted based on anatomy, (i.e., annual, routine screening for chlamydia in cisgender women < 25 years old should be extended to all transgender men and gender diverse people with a cervix.
Oct 28, 2021 · Screening recommendations for cisgender women regarding gonorrhea, chlamydia, and cervical cancer should be extended to all transgender men and gender-diverse people with a cervix. Screening at the pharyngeal and rectal sites for gonorrhea and chlamydia should be considered based on reported sexual behaviors and exposure.
Sep 13, 2023 · This rationale underlies the recommendation to screen for gonorrhea and chlamydia more clearly among cisgender women than cisgender men, because cisgender women are at risk for pelvic inflammatory disease and infertility from these infections, whereas clinical sequelae are less common, and generally less morbid, for cisgender men. 3 This ...
- Follow-Up
- Management of Sex Partners
- Special Considerations
Test of cure to detect therapeutic failure (i.e., repeat testing 4 weeks after completing therapy) is not advised for nonpregnant persons treated with the recommended or alternative regimens, unless therapeutic adherence is in question, symptoms persist, or reinfection is suspected. Moreover, using chlamydial NAATs at <4 weeks after completion of t...
Sex partners should be referred for evaluation, testing, and presumptive treatment if they had sexual contact with the partner during the 60 days preceding the patient’s onset of symptoms or chlamydia diagnosis. Although the exposure intervals defining identification of sex partners at risk are based on limited data, the most recent sex partner sho...
Pregnancy
Clinical experience and published studies indicate that azithromycin is safe and effective during pregnancy (824–826). Doxycycline is contraindicated during the second and third trimesters of pregnancy because of risk for tooth discoloration. Human data reveal that levofloxacin presents a low risk to the fetus during pregnancy but has potential for toxicity during breastfeeding; however, data from animal studies increase concerns regarding cartilage damage to neonates (431). Test of cure (i.e...
Sep 29, 2021 · Based on its review of the available evidence, the task force recommended screening for chlamydia and gonorrhea in all sexually active women, including pregnant people, if they are 24 years...
- Michael Devitt
Mar 25, 2022 · Screening Indications for Chlamydial Infection in MSM. Resuming Sexual Activity After Treatment for Chlamydia. A 21-year-old cisgender man has several sexual relationships with cisgender women while living away from his home during a summer work project.
Mar 24, 2021 · Women: Screening for chlamydia in sexually active women age 24 years and younger and in older women who are at increased risk for infection (Grade B). Men: Current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men (Grade I).
